Cardiology

On-pump CABG leads to higher rates of five-year survival

(HealthDay)—Five years after coronary-artery bypass grafting (CABG) surgery, patients whose operation was performed with cardiopulmonary bypass (on pump) lived longer than those whose surgeons performed the procedure without ...

Cardiology

High-risk plaque on coronary CTA linked to future MACE

(HealthDay)—For outpatients with stable chest pain, high-risk plaque found by coronary computed tomographic angiography (CTA) is associated with subsequent major adverse cardiovascular events (MACE), according to a study ...

Cardiology

Genetic test helps improve outcomes in heart stent patients

A genetic test recently implemented at UPMC Presbyterian can significantly reduce the risk of cardiovascular events by helping to identify more effective medication for some heart patients, according to the results of a large ...

Cardiology

CYP2C19-genotype guided antiplatelet tx may be beneficial

(HealthDay)—Patients with a CYP2C19 loss-of-function allele have increased risk of major adverse cardiovascular events (MACE) with clopidogrel versus alternative antiplatelet therapy after percutaneous coronary intervention ...

Cardiology

DAPT cessation patterns vary with diabetes status after PCI

(HealthDay)—For patients undergoing dual antiplatelet therapy (DAPT) after percutaneous coronary intervention with a drug-eluting stent (DES), DAPT cessation is significantly lower in patients with diabetes mellitus (DM), ...

Cardiology

Previous stroke tied to higher risks in aortic valve replacement

(HealthDay)—For patients undergoing surgical aortic valve replacement (SAVR), previous stroke is a risk factor for recurrent ischemic stroke and major adverse cardiovascular events (MACE), according to a study published ...

page 3 from 6